Previous close | 20.84 |
Open | 21.06 |
Bid | 20.79 x 100 |
Ask | 20.87 x 100 |
Day's range | 20.71 - 21.06 |
52-week range | 18.61 - 30.52 |
Volume | |
Avg. volume | 709,592 |
Market cap | 1.59B |
Beta (5Y monthly) | 1.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.93 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 29.83 |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Veracyte's (VCYT) new studies leverage Afirma GRID's whole-transcriptome approach to uncover novel molecular signatures and alterations.
We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These stocks are: ALC, RXST, HOLX, VCYT, MASI.